Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer (IMAGE)
Caption
A Screenshot from Journal of Medicinal Chemistry Website
Credit
Journal of Medicinal Chemistry
Usage Restrictions
No restrictions.
License
Public Domain